# OLANZAPINE
> **ANDA217466** · Abbreviated New Drug Application (Generic) · Sponsor: ASPIRO · Approved 2023-03-22
## Drug
- **FDA Application Number:** ANDA217466
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OLANZAPINE
- **Generic name:** OLANZAPINE
- **Active ingredients:** OLANZAPINE
- **Dosage form:** POWDER
- **Route:** INTRAMUSCULAR
- **Marketing status:** Prescription
- **Sponsor:** ASPIRO
- **Manufacturer:** Camber Pharmaceuticals, Inc.
- **First approval:** 2023-03-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217466)
---
*MORVS · CC0 1.0*